SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab shares are receiving attention following the announcement of a new high-efficiency solar cell that reduces reliance on supply-constrained minerals. While many traders are optimistic about the firm's end-to-end space capabilities and the upcoming Iridium acquisition, others express frustration over share dilution and skepticism regarding the Neutron rocket's development timeline.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending due to a strong fiscal fourth-quarter earnings report that exceeded analyst expectations and featured robust fiscal year 2027 guidance. Traders are reacting positively to the company's substantial order backlog and capacity expansion plans, viewing the firm as a key beneficiary of the ongoing AI data center and electrical infrastructure buildout.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending as the community anticipates the upcoming Phase 3 eGFR data readout, which many investors view as a pivotal binary event that could trigger a significant re-rating of the stock. Traders are expressing high conviction in the drug's potential, frequently citing strong short interest and institutional ownership as catalysts for a possible breakout.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The index is experiencing significant volatility as investors weigh the Federal Reserve's looming interest rate decision against concerns over AI sector sustainability and rising Treasury yields. While traders are debating the impact of AI development calls and geopolitical tensions, the market has shown a notable resilience, with many participants continuing to favor 'buying the dip' strategies despite the bearish sentiment and macro pressures.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon is experiencing significant volatility as traders debate the impact of heavy insider selling by company executives and the stock's high valuation relative to its software business model. While some remain bullish on the company's long-term growth in public safety technology, others are actively shorting the stock, viewing recent price movements as an unsustainable "Trump pump" or prone to manipulation.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

Semiconductor stocks faced a sharp decline as industry leaders discussed pacing the development of frontier artificial intelligence, raising concerns among traders about the potential impact on infrastructure spending and the long-term AI buildout. This development, coupled with broader market volatility and uncertainty regarding Federal Reserve policy, led to a significant rotation out of chipmakers and into software stocks.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is trending as investors show strong interest in its pending merger with Agility Robotics, a company positioned as a pure-play U.S. humanoid robotics leader backed by major tech firms like NVIDIA and Amazon. Traders are expressing significant bullish sentiment, citing Agility's established commercial deployments and the broader humanoid robotics sector as a high-growth thematic opportunity.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is trending as investors react to the completion of the acquisition of Chain Technology and Services, which aims to integrate real-world payments infrastructure into the Onyx ecosystem. While some traders view this development as a foundational step toward a blockchain-native neobank and potential institutional adoption, others express skepticism, characterizing the price action as a pump-and-dump scheme and citing concerns over dilution.

Corsair Gaming, Inc. designs and supplies hardware components for personal computers. It operates through the Gamer and Creator Peripherals, and Gaming Components and Systems segments. The Gamer and Creator Peripherals segment offers gaming keyboards, mice, headsets, controllers, and gaming gear including capture cards, Stream Decks, USB microphones, studio accessories, and EpocCam software, as well as coaching and training services. The Gaming Components and Systems segment focuses on creating power supply units, or PSUs, cooling solutions, computer cases, DRAM modules, prebuilt, and custom-built gaming PCs. The company was founded by Andrew J. Paul in 1994 and is headquartered in Milpitas, CA.

Corsair Gaming Inc

Corsair Gaming is receiving attention as traders monitor its recent share price appreciation, with sentiment heavily focused on potential short squeeze dynamics driven by a significant short interest. Supporters point to strong margins, product demand in sim racing and peripherals, and a perceived turnaround as evidence that the company is undervalued compared to peers.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending primarily due to the release of positive Phase 3 topline results for its plozasiran studies in patients with severe hypertriglyceridemia, which demonstrated significant and durable triglyceride reduction along with a reduction in acute pancreatitis events. The community discussion is focused on the potential for commercialization, the impact of these results on the competitive landscape with other therapies, and the broader validation of the company's RNAi platform.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Stocktwits

The Fed's rate decision comes Wednesday at 2PM ET. What do you think happens?

Feed

News

Sentiment

Fundamentals

Info

About EEGBF